Literature DB >> 34036500

Increasing mortality caused by chronic obstructive pulmonary disease (COPD) in relation with exposure to ambient fine particulate matters: an analysis in Southeastern China.

Zhijian Chen1, Qiuli Fu2, Guangming Mao1, Lizhi Wu1, Peiwei Xu1, Dandan Xu1, Zhifang Wang1, Xuejiao Pan1, Yuan Chen1, Xiaoming Lou1, Zhe Mo3, Xiaofeng Wang4, Yuanqun Feng5.   

Abstract

The objective of this study was to investigate the association between ambient particulate matters (PMs) and chronic obstructive pulmonary disease (COPD) mortality. generalized additive mixed model was employed to investigate the effects of ambient fine and coarse PMs on COPD mortality using 13,066 deaths from 2014 to 2016 among six cities in Zhejiang Province in Southeastern China. The daily average death count due to COPD was 3, varying from 1 to 7 among six cities. The daily 24-h mean concentrations were diverse among cities, from 29.7 to 56.8 μg/m3 for PM2.5, 16.7 to 30.3 μg/m3 for PM2.5-10, and 50.3 to 87.1 μg/m3 for PM10, respectively. The analysis showed that daily exposure to PM2.5 and PM10 was associated with increased mortality due to COPD and that weak effects were observed between PM2.5-10 and COPD mortality. Our results provided solid evidence that the fine particles in air pollution have stronger functions on adverse health effects other than coarser particles in Southeastern China, which may be considered as a potential clinic target in PM-associated COPD.

Entities:  

Keywords:  Air pollution; Chronic obstructive pulmonary disease; Generalized additive mixed model; Health; Mortalities; Particulate matters

Year:  2021        PMID: 34036500     DOI: 10.1007/s11356-021-14009-y

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  1 in total

1.  Disparities in COPD Hospitalizations: A Spatial Analysis of Proximity to Toxics Release Inventory Facilities in Illinois.

Authors:  Stacey Brown-Amilian; Yussuf Akolade
Journal:  Int J Environ Res Public Health       Date:  2021-12-13       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.